A 72-year-old woman with a history of small-cell lung cancer (SCLC) treated 6 months ago presents with progressive confusion and nausea over 2 weeks. She denies polyuria or polydipsia. On examination, she is euvolemic with no peripheral edema. Laboratory findings: serum sodium 124 mEq/L, serum osmolality 258 mOsm/kg, urine osmolality 620 mOsm/kg, urine sodium 78 mEq/L, and TSH 2.1 mIU/L. Chest X-ray shows no recurrent malignancy. What is the most appropriate initial management?

Explanation

## Diagnosis: SIADH This patient has **Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)** secondary to prior small-cell lung cancer (SCLC), one of the most common malignancy-associated causes. ## Diagnostic Criteria for SIADH **Key Point:** SIADH is diagnosed when all of the following are present: | Criterion | Patient's Values | Status | |-----------|------------------|--------| | **Hyponatremia** | 124 mEq/L | ✓ Present (< 135) | | **Low serum osmolality** | 258 mOsm/kg | ✓ Present (< 280) | | **Urine osmolality > serum osmolality** | 620 mOsm/kg | ✓ Present (inappropriately high) | | **Euvolemia** | Euvolemic on exam | ✓ Present (no edema, normal BP) | | **Normal thyroid & adrenal function** | TSH 2.1 mIU/L | ✓ Present (normal TSH) | | **No diuretic use** | Not mentioned | ✓ Assumed absent | **Mnemonic: SIADH Causes — CHAMPS** - **C**NS disease (meningitis, encephalitis, head trauma, seizures) - **H**eadache, **H**ypertension, **H**ypoxia - **A**dvanced malignancy (SCLC, pancreatic, bladder cancers) - **M**edications (SSRIs, carbamazepine, vincristine, NSAIDs, desmopressin) - **P**ulmonary disease (tuberculosis, pneumonia, positive pressure ventilation) - **S**tress (pain, surgery, nausea) ## Management Strategy for Euvolemic Hyponatremia in SIADH **High-Yield:** The severity of hyponatremia and presence/absence of symptoms determine management urgency: ```mermaid flowchart TD A[SIADH Diagnosed]:::outcome --> B{Symptomatic?}:::decision B -->|Yes: Seizures, LOC, coma| C[Hypertonic 3% saline<br/>1-2 mL/kg/hr]:::action B -->|No: Asymptomatic or mild| D{Acute vs Chronic?}:::decision D -->|Acute onset<br/>< 48 hrs| E[Hypertonic saline<br/>or fluid restriction]:::action D -->|Chronic onset<br/>> 48 hrs| F[Fluid restriction<br/>800-1000 mL/day]:::action C --> G[Target: 8-10 mEq/L<br/>per 24 hours]:::outcome E --> G F --> H[Monitor Na+ q6-12h<br/>Gradual correction]:::action ``` ## Why Fluid Restriction Is Correct Here This patient is: - **Asymptomatic** (confusion is chronic, not acute neurological emergency) - **Euvolemic** (no signs of hypovolemia or hypervolemia) - **Chronic hyponatremia** (progressive over 2 weeks, not acute) **Clinical Pearl:** Fluid restriction is the first-line treatment for euvolemic, asymptomatic SIADH because it addresses the underlying pathophysiology: ADH is causing the kidneys to reabsorb free water despite low serum osmolality. Restricting water intake prevents further dilution. **Target:** Restrict to 800 mL/day (or 50% of insensible losses + urine output). Monitor serum sodium every 6 hours initially, then daily once stable. ## Correction Rate: The Osmotic Demyelination Syndrome (ODS) Risk **Warning:** Rapid correction of chronic hyponatremia (> 12 mEq/L per 24 hours) causes **osmotic demyelination syndrome** — irreversible central pontine and extrapontine myelinolysis. - **Safe correction rate:** 8–10 mEq/L per 24 hours - **Maximum safe rate:** 12 mEq/L per 24 hours (only if symptomatic) - **Fluid restriction achieves:** Gradual, physiologic correction (1–2 mEq/L per day) ## Why Each Distractor Is Wrong 1. **Hypertonic saline** — Reserved for SYMPTOMATIC hyponatremia with neurological signs (seizures, altered mental status from acute hyponatremia, not chronic confusion). This patient's confusion is likely chronic and not acutely life-threatening. 2. **Normal saline** — CONTRAINDICATED in SIADH. The kidneys will reabsorb the water from 0.9% saline (which is hypotonic relative to urine osmolality of 620), worsening hyponatremia. 3. **Desmopressin (DDAVP)** — This is ADH; giving it would worsen SIADH. DDAVP is used to TREAT diabetes insipidus (opposite problem), not SIADH.